Based on these immunological studies, PAQR4 expression can significantly affect the composition of different immune cells in the tumor microenvironment and participate in different pathways to modulate the immune response of the tumor, which may be associated with poor prognosis in the high PAQR4 group. This evidence concerns the gene PAQR4 and neoplasm.